Détail de la notice
Titre du Document
Growth Factors, Inflammatory Cytokines and Postnatal Bone Strength in Preterm Infants
Auteur(s)
ELIAKIM Alon ; NEMET Dan ; AHMAD Irfan ; ...
Résumé
Aim: To assess the relationships between growth factors, inflammatory cytokines and postnatal bone development in preterm infants. Methods: Fifty premature infants (24-32 weeks gestational age, mean birth weight: 1,024 ± 50 g) participated in the study. Bone strength was determined weekly by quantitative ultrasound measurements of bone speed of sound (SOS). Blood serum measurements of growth factors included circulating IGF-I and GH binding protein. Measurements of circulating cytokines included the pro-inflammatory mediator interleukin (IL)-6, and the anti-inflammatory mediator IL-1 receptor antagonist. Samples were collected when the preterm infants were stabilized and prior to discharge. Results: Despite a significant increase in body weight (from 1,024 ± 50 to 2,420 ± 59 g, p <0.001) and body length (from 35.4 ± 0.6 to 44.6 ± 0.4 cm, p <0.001) there was a significant decrease in bone SOS during the follow-up period. There was a significant increase in growth factors and a decrease in inflammatory cytokines during the follow-up. Participants were divided into preterm infants who increased bone SOS (bone gainers, n = 16, from 2,867 ± 38 to 2,910 ± 41 m/sec), or decreased bone SOS (bone losers, n = 34, from 2,967 ± 33 to 2,818 ± 28 m/sec) during follow-up. Baseline bone SOS was significantly lower in the bone gainers. Baseline circulating growth factors were higher and inflammatory cytokines lower in the bone gainers; however, only the difference in IL-6 reached sta
Editeur
Freund
Identifiant
ISSN : 0334-018X
Source
Journal of pediatric endocrinology & metabolism A. 2009, vol. 22, n° 8, pp. 733-740 [8 pages]
Langue
Anglais
Pour les membres de la communauté du CNRS, ce document est autorisé à la reproduction à titre gratuit.
Pour les membres des communautés hors CNRS, la reproduction de ce document à titre onéreux sera fournie sous réserve d’autorisation du Centre Français d’exploitation du droit de Copie.

Pour bénéficier de nos services (strictement destinés aux membres de la communauté CNRS (Centre National de la Recherche Scientifique), de l'ESR français (Enseignement Supérieur et Recherche), et du secteur public français & étranger) :